These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 10625224)
1. L-NAME-induced protein remodeling and fibrosis in the rat heart. Pechánová O; Bernátová I; Pelouch V; Babál P Physiol Res; 1999; 48(5):353-62. PubMed ID: 10625224 [TBL] [Abstract][Full Text] [Related]
2. Heart remodeling in the hereditary hypertriglyceridemic rat: effect of captopril and nitric oxide deficiency. Simko F; Luptak I; Matuskova J; Babal P; Pechanova O; Bernatova I; Hulin I Ann N Y Acad Sci; 2002 Jun; 967():454-62. PubMed ID: 12079874 [TBL] [Abstract][Full Text] [Related]
3. Effect of captopril on cyclic nucleotide concentrations during long-term NO synthase inhibition. Pechánová O; Bernátová I Physiol Res; 2000; 49(1):55-63. PubMed ID: 10805405 [TBL] [Abstract][Full Text] [Related]
4. Regression of chronic L -NAME-treatment-induced left ventricular hypertrophy: effect of captopril. Bernátová I; Pechánová O; Pelouch V; Simko F J Mol Cell Cardiol; 2000 Feb; 32(2):177-85. PubMed ID: 10722795 [TBL] [Abstract][Full Text] [Related]
5. Sildenafil reduces L-NAME-induced severe hypertension and worsening of myocardial ischaemia-reperfusion damage in the rat. Rossoni G; Manfredi B; De Gennaro Colonna V; Berti M; Guazzi M; Berti F Br J Pharmacol; 2007 Mar; 150(5):567-76. PubMed ID: 17245365 [TBL] [Abstract][Full Text] [Related]
7. Angiotensin II type 1 receptor blocker prevents atrial structural remodeling in rats with hypertension induced by chronic nitric oxide inhibition. Okazaki H; Minamino T; Tsukamoto O; Kim J; Okada K; Myoishi M; Wakeno M; Takashima S; Mochizuki N; Kitakaze M Hypertens Res; 2006 Apr; 29(4):277-84. PubMed ID: 16778335 [TBL] [Abstract][Full Text] [Related]
8. Sildenafil augments the beneficial hemodynamic and histopathological effects of amlodipine in nitric oxide-deficient hypertensive rats: role of nitric oxide-cyclic GMP pathway. Aboutabl ME; Raafat M; Maklad YA; Kenawy SA; El Din AG Pharmacol Res; 2008 Jun; 57(6):456-63. PubMed ID: 18572415 [TBL] [Abstract][Full Text] [Related]
9. Melatonin prevents fibrosis but not hypertrophy development in the left ventricle of NG-nitro-L-arginine-methyl ester hypertensive rats. Paulis L; Pechanova O; Zicha J; Krajcirovicova K; Barta A; Pelouch V; Adamcova M; Simko F J Hypertens Suppl; 2009 Aug; 27(6):S11-6. PubMed ID: 19633445 [TBL] [Abstract][Full Text] [Related]
10. Long-acting Ca2+ blockers prevent myocardial remodeling induced by chronic NO inhibition in rats. Sanada S; Node K; Minamino T; Takashima S; Ogai A; Asanuma H; Ogita H; Liao Y; Asakura M; Kim J; Hori M; Kitakaze M Hypertension; 2003 Apr; 41(4):963-7. PubMed ID: 12629037 [TBL] [Abstract][Full Text] [Related]
11. Effect of captopril in L-NAME-induced hypertension on the rat myocardium, aorta, brain and kidney. Bernátová I; Pechánová O; Simko F Exp Physiol; 1999 Nov; 84(6):1095-105. PubMed ID: 10564706 [TBL] [Abstract][Full Text] [Related]
12. Structural alterations in the heart after long-term L-NAME and D-NAME treatment. Pechánová O; Bernátová I; Babál P Gen Physiol Biophys; 1999 Dec; 18 Suppl 1():6-9. PubMed ID: 10707823 [TBL] [Abstract][Full Text] [Related]
13. The antagonism of aldosterone receptor prevents the development of hypertensive heart failure induced by chronic inhibition of nitric oxide synthesis in rats. Tsukamoto O; Minamino T; Sanada S; Okada K; Hirata A; Fujita M; Shintani Y; Yulin L; Asano Y; Takashima S; Yamasaki S; Tomoike H; Hori M; Kitakaze M Cardiovasc Drugs Ther; 2006 Apr; 20(2):93-102. PubMed ID: 16761190 [TBL] [Abstract][Full Text] [Related]
14. Myocardial vasoactive intestinal peptide and fibrosis induced by nitric oxide synthase inhibition in the rat. Ye VZ; Hodge G; Yong JL; Duggan KA Acta Physiol Scand; 2003 Dec; 179(4):353-60. PubMed ID: 14656372 [TBL] [Abstract][Full Text] [Related]
15. Protein remodelling of the heart in NO-deficient hypertension: the effect of captopril. Pechánová O; Bernátová I; Pelouch V; Simko F J Mol Cell Cardiol; 1997 Dec; 29(12):3365-74. PubMed ID: 9441842 [TBL] [Abstract][Full Text] [Related]
16. Chronic inhibition of nitric oxide synthesis causes coronary microvascular remodeling in rats. Numaguchi K; Egashira K; Takemoto M; Kadokami T; Shimokawa H; Sueishi K; Takeshita A Hypertension; 1995 Dec; 26(6 Pt 1):957-62. PubMed ID: 7490155 [TBL] [Abstract][Full Text] [Related]
17. Captopril prevents NO-deficient hypertension and left ventricular hypertrophy without affecting nitric oxide synthase activity in rats. Bernátová I; Pechánová O; Simko F Physiol Res; 1996; 45(4):311-6. PubMed ID: 9085355 [TBL] [Abstract][Full Text] [Related]
18. Chronic nitric oxide synthase blockade desensitizes the heart to the negative metabolic effects of nitric oxide. Davidov T; Weiss HR; Tse J; Scholz PM Life Sci; 2006 Sep; 79(17):1674-80. PubMed ID: 16831448 [TBL] [Abstract][Full Text] [Related]
19. Nitric oxide synthase inhibition promotes carcinogen-induced preneoplastic changes in the colon of rats. Schleiffer R; Duranton B; Gossé F; Bergmann C; Raul F Nitric Oxide; 2000 Dec; 4(6):583-9. PubMed ID: 11139366 [TBL] [Abstract][Full Text] [Related]